Amplifon stock: October 29 results test Amplifon stock margins

Published on 10/23/2026 at 15:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EBITDA rose 3.60 percent to EUR 298.00 million through June. Amplifon stock costs EUR 12.83 on October 23, 2026, down 0.47 percent versus close.

Reporting date October 29, 2026

Amplifon scheduled third-quarter results and a shareholder meeting for October 29, 2026.
Adjusted EBITDA rose 3.60 percent to EUR 298.00 million in the first half of 2026.
Amplifon stock costs EUR 12.83 at Lang & Schwarz on October 23, 2026, down 0.47 percent versus the Borsa Italiana close of October 22, 2026.
Market capitalization stood at EUR 2.8 billion on October 23, 2026.

Isometrische 3D-Illustration einer Wertschöpfungskette von Diagnose bis Verkauf — Isometrische 3D-Grafik der Wertschöpfungskette veranschaulicht Geschäftsmodell von Amplifon S.p.A., ISIN IT0004056880, im Gesundheitssektor, Illustration mit AI erstellt.

Amplifon (IT0004056880) has set October 29, 2026 for its third-quarter results and a shareholder meeting linked to the GN Hearing transaction. The company published the meeting notice on September 29, 2026, while Morningstar also identified October 29 as the next reporting date. Amplifon was trading at EUR 12.83 at Lang & Schwarz on October 23, 2026 at 3:40 p.m. CEST, down 0.47 percent versus the Borsa Italiana close of October 22, 2026.

First-half margins set the test

The upcoming release will show whether the operating improvement reported for the first half continued into the third quarter. Rankia reported first-half revenue of EUR 1.19 billion, up 1.30 percent at constant exchange rates, while organic growth reached 3.50 percent. Adjusted EBITDA increased 3.60 percent to EUR 298.00 million, and the adjusted EBITDA margin reached 25.10 percent, an improvement of 0.70 percentage points.

The second quarter supplied the sharper comparison. Organic growth accelerated to 4.70 percent, while adjusted EBITDA increased 6.10 percent and the adjusted net profit rose 17.10 percent, according to the same report. Those figures give the October release a clear operating benchmark without relying on the stock price alone.

Stock remains below its yearly high

Amplifon traded within a EUR 7.84 to EUR 15.80 52-week range on October 23, 2026. At EUR 12.83, the stock stood 18.80 percent below the yearly high and 63.52 percent above the low. The company had a market capitalization of EUR 2.8 billion and a price-to-earnings ratio of 42.46 on the same date.

Targets meet the October date

Corriere reported on October 9, 2026 that Morgan Stanley raised its Amplifon target to EUR 14.96 from EUR 14.90 and maintained an Overweight rating. The new target was 16.61 percent above the Lang & Schwarz price on October 23, 2026. Investing.com listed 16 analysts, with seven Buy ratings and nine Holds, and an average target of EUR 13.63.

The October 29 schedule combines an operating update with a corporate decision on the GN Hearing transaction. The shareholder meeting notice names the date and the proposed measures, while the results will indicate whether first-half growth and margin gains held through the summer.

What the next release must clarify

For investors, the key evidence will be the third-quarter revenue trend, the adjusted margin and management's comments on integration. Amplifon's first-half adjusted free cash flow reached EUR 68.00 million, up 70.00 percent from the first half of 2025, adding a cash-generation measure to the margin discussion. The combination of stronger organic growth and the planned acquisition keeps both execution and balance-sheet progress relevant.

Amplifon was trading at EUR 12.83 at Lang & Schwarz on October 23, 2026 at 3:40 p.m. CEST, down 0.47 percent versus the Borsa Italiana close of October 22, 2026.

The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.